FUFENG GROUP (00546) experienced a rise of more than 7% before the midday break. As of the time of writing, the stock was up 7.23%, trading at HK$9.19, with a turnover of HK$68.1024 million. The company recently announced that, due to increasing raw material costs and tight supply, it will raise the prices of threonine, lysine, and minor amino acid products effective immediately. The price increases range from RMB 100 to 500 per ton, with priority given to ensuring stable supply for core customers. An industry research report noted that after multiple rounds of consolidation driven by environmental policies and technical barriers, the competitive landscape has significantly improved. The monosodium glutamate market has become a highly concentrated oligopoly, with competition becoming more rational. Beyond monosodium glutamate, FUFENG GROUP also holds a leading domestic position in segments such as animal nutrition and xanthan gum. This diversification helps effectively cushion overall performance fluctuations, even when毛利率 declines in certain product categories. The group has maintained a stable high-dividend policy in recent years, which holds strong appeal for some long-term investors.